{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for glutathione root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
NCT03622658: Phase 2 Interventional Completed Axial Spondyloarthritis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00954642: Phase 1 Interventional Completed Solid Cancers
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02289950: Phase 2 Interventional Completed Platinum-Sensitive Ovarian Cancer in First Relapse
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01941537: Phase 2 Interventional Completed Atopic Dermatitis
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00278187: Phase 2 Interventional Unknown status Lung Cancer
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00103558: Phase 1/Phase 2 Interventional Completed Chronic Lymphocytic Leukemia
(2004)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00132522: Phase 1 Interventional Completed Ovarian Cancer
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01327612: Phase 2 Interventional Completed Advanced Solid Tumors
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01760005: Phase 2/Phase 3 Interventional Recruiting Alzheimers Disease
(2012)
Source URL:
Class:
PROTEIN
Status:
Designated
Source:
FDA ORPHAN DRUG:906122
Source URL:
Class:
PROTEIN